D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
The ICD-10-CM code for Hemorrhagic disorder due to extrinsic circulating anticoagulants is D68.32 (FY2026). It is a billable, claim-ready diagnosis code.
Classification
- Section
- D65-D69: Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
- Category D68
- 32 codes (25 billable)
- FY2026 Status
- Stable since FY2024
Also Known As
ICD-10-CM Alphabetic Index entries that lead to D68.32:
- Hyperheparinemia
- Anticoagulant, circulating (intrinsic) › iatrogenic
- Circulating anticoagulants › due to drugs
- Disorder (of) › drug induced hemorrhagic
- Anticoagulant, circulating (intrinsic) › drug-induced (extrinsic)
- Disorder (of) › hemorrhagic NEC › drug-induced
- Disorder (of) › hemorrhagic NEC › due to › extrinsic circulating anticoagulants
- Disorder (of) › hemorrhagic NEC › due to › increase in › anti-IIa
Inclusion Terms
- Drug-induced hemorrhagic disorder
- Hemorrhagic disorder due to increase in anti-IIa
- Hemorrhagic disorder due to increase in anti-Xa
- Hyperheparinemia
U.S. Hospital Utilization
- An estimated 103,960 U.S. inpatient stays in 2023 included D68.32 among the documented diagnoses.
- 24,165 stays listed it as the principal diagnosis.
Source: National Inpatient Sample (NIS), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, 2016–2023. National survey-weighted estimates.
Official Coding Guidelines
Chapter 3 TOC entry3. Chapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) ............................................................................................. 39
Reserved for future guideline expansionReserved for future guideline expansion ...................................................................................... 39
Source: CMS — ICD-10-CM Official Guidelines for Coding and Reporting, FY2026